Steven Cohen’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Steven Cohen's ACAD Position: Q3 2026 in Review
Steven Cohen reduced its Acadia Pharmaceuticals (ACAD) stake by 53% in Q3 2026, selling an estimated $34.8M and leaving 1,135,983 shares worth $22.9M. The position accounts for 0.03% of the portfolio, ranked #838.
Steven Cohen first reported a position in ACAD in Q2 2014 and has held it in 40 quarters since. The position peaked at $97.9M in Q1 2018. 348 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Steven Cohen held 1,135,983 shares of Acadia Pharmaceuticals worth $22.9M as of Q3 2026.
- Steven Cohen sold 1,297,185 Acadia Pharmaceuticals shares in Q3 2026, an estimated $34.8M.
- Acadia Pharmaceuticals made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #838 holding.
- Steven Cohen first reported a position in Acadia Pharmaceuticals in Q2 2014 and has held it in 40 quarters since.
- Steven Cohen's Acadia Pharmaceuticals position peaked at $97.9M in Q1 2018.
- 348 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.